doi:https://doi.org/

References:

Alexander J.H., Smith P.K. Coronary-artery bypass grafting. N Engl J Med 2016;374:1954—1964.
Aldea G.S., Bakaeen F.G., Pal J., et al; Society of Thoracic Surgeons. The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting. Ann Thorac Surg 2016;101:801—809.
Halabi A.R., Alexander J.H., Shaw L.K., et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 2005;96:1254—1259.
Gaudino M., Antoniades C., Benedetto U., et al; ATLANTIC (Arterial Grafting International Consortium) Alliance. Mechanisms, consequences, and prevention of coronary graft failure. Circulation 2017;136:1749—1764.
Yusuf S., Zhao F., Mehta S.R., et al; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494—502.
Wiviott S.D., Braunwald E., McCabe C.H., et al; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001—2015.
Wallentin L., Becker R.C., Budaj A., et al; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045—1057.
Gao C., Ren C., Li D., Li L. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg 2009;88:59—62.
Gao G., Zheng Z., Pi Y, et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J Am Coll Cardiol 2010;56:1639—1643.
Sun J.C., Teoh K.H., Lamy A., et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. Am Heart J 2010;160:1178—1184.
Saw J., Wong G.C., Mayo J., et al. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery. Heart 2016;102:763—769.
Bonaca M.P., Bhatt D.L., Cohen M., et al; PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 2015;372:1791—1800.
Held C., Asenblad N., Bassand J.P., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011;57:672—684.
Fox K.A., Mehta S.R., Peters R., et al; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non–ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) trial. Circulation 2004;110:1202—1208.